FORM 1571 – Used only for IND studies: This form must accompany the initial IND submission. It will contain serial number 0000 for the initial submission. This form is required to accompany all subsequent submissions to the IND. The serial number should be adjusted with each submission, (i.e. 0000, 0001, 0002.etc.)

Regulatory Templates & Forms

FORM 1571 – Used only for IND studies: This form must accompany the initial IND submission. It will contain serial number 0000 for the initial submission. This form is required to accompany all subsequent submissions to the IND. The serial number should be adjusted with each submission, (i.e. 0000, 0001, 0002.etc.)

Key components of the FDA Form 1571

  • Contractual agreement between sponsor and FDA
  • Name of person responsible for conduct and progress of the study (Item 14)
  • Name of person responsible for the review and evaluation of safety information on the drug (Item 15)
  • Sponsor agrees to conduct investigation in accordance with all applicable regulatory requirements (Item16)

FORM 1572 – Used only for IND studies This form should accompany the initial IND submission. If multicenter, each site should have its own 1572. NOTE: Anyone performing clinical assessments should go on the 1572. This may include Physician Assistants, Nurse Practitioners, etc.

Key components of the FDA Form 1572

  • Contractual agreement between an Investigator and the Sponsor
  • Name of person responsible for conduct an investigation and their credentials
  • Listing of the facilities and labs that are participating in the investigation
  • Listing of the IRB responsible for reviewing/approving study
  • Listing of additional Sub-Investigators
  • Investigator agrees to conduct investigation in accordance with all applicable regulatory requirements (Item 9 - Commitments)

Form 3674 – Used for IND and IDE studies This form must accompany the initial IND or IDE submission as well as the addition of a new protocol to an existing IND or IDE. This is a new requirement as of December 2007. This is a Certification of Compliance that all requirements of the Public Health Service Act (42 USC§ 282(j)) have been met (in essence, compliance with registration in clinicaltrials.gov. learn more »)

FORM 3500A – Used for IND and IDE studies (Also referred to as “Medwatch Form”). It is for use by user facilities, distributors, importers, applicants, and manufacturers for MANDATORY reporting of adverse events and product problems as designated in the applicable statutes and FDA regulations.

VAERS form – Used to report vaccine adverse events.

Templates and Instructional Documents

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UL1TR002489

© 2008-2021 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact